GIST
Here below, you will find a list of all the latest content published on this website on the topic of GIST. The content is published in chronological order. Find out more about our content categorisation.
-
« Previous
- 1
- 2
- ...
- 7
-
Next »
- Quantitative Multiplexed Immune Profiling of Advanced Gastrointestinal Stromal Tumors (GISTs): Impact of tyrosine kinase inhibitors on immune envir...
- Multicentric retrospective analysis of patients with KIT exon 9 mutated GIST.
- Prognostic factors for residual lesion surgery following disease control with standard dose imatinib (IM) treatment in patients (pts) with advanced...
- Systemic steroid treatment for severe skin rash induced by imatinib in patients with gastrointestinal stromal tumor (GIST): A phase II study
- Phase II study of paclitaxel in patients with advanced gastrointestinal stromal tumor (GIST) after failure of at least both imatinib and sunitinib
- Heat shock protein 90 (HSP90) inhibitor as a candidate treatment option for gastrointestinal stromal tumor with acquired resistance for conventiona...
- Correlation of ctDNA and response in patients (pts) with PDGFR_ D842 GIST treated with avapritinib
- VOYAGER: An open-label, randomised, Phase 3 study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresec...
- Stromal progesterone receptor expression and long-term survival in patients with resected periampullary adenocarcinoma
- State of Art: Recommendation for adjuvant treatment in GIST
- Initial Results of Phase 1 Study of DCC-2618, a Broad-spectrum KIT and PDGFRa Inhibitor, in Patients (pts) with Gastrointestinal Stromal Tumor (GIS...
- PDGFRA in Gastrointestinal Stromal Tumours (GIST): ESMO Biomarker Factsheet
- KIT and PDGFRA Wild-type Gastrointestinal Stromal Tumours (GISTs): ESMO Biomarker Factsheet
- KIT in Gastrointestinal Stromal Tumours (GIST): ESMO Biomarker Factsheet
- What is new in GIST in the last 12 months?
- GIST
- Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Dasatinib Active In Some Advanced Imatinib-Refractory GIST Patients
- Spotlight session - Case based management of sarcomas and GIST
- ESMO Sarcoma and GIST Conference: Highlights From Round Table With SPAEN
- Evidence-based data for Sarcoma and GIST: A True Challenge
- ESMO Sarcoma and GIST Symposium 2018
- Will ERN improve quality of care of STS & GIST in the EU?
- Insights to Sarcoma and GIST in India
- Is there a rationale for immune therapy in GIST?
-
« Previous
- 1
- 2
- ...
- 7
-
Next »